Publication | Open Access
Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer
33
Citations
20
References
2018
Year
Continuous low dosage administration of olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1